James LaBelle, MD, PhD - UChicago Medicine

Dr. James Labelle

Claim this profile

University of Chicago

Studies Aplastic Anemia
Studies Sickle Cell Disease
6 reported clinical trials
17 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Chicago
Image of trial facility.
University Of Chicago SC

Clinical Trials James Labelle is currently running

Image of trial facility.

IST + BMT

for Aplastic Anemia

Severe Aplastic Anemia (SAA) is a rare condition in which the body stops producing enough new blood cells. SAA can be cured with immune suppressive therapy or a bone marrow transplant. Regular treatment for patients with aplastic anemia who have a matched sibling (brother or sister), or family donor is a bone marrow transplant. Patients without a matched family donor normally are treated with immune suppressive therapy (IST). Match unrelated donor (URD) bone marrow transplant (BMT) is used as a secondary treatment in patients who did not get better with IST, had their disease come back, or a new worse disease replaced it (like leukemia). This trial will compare time from randomization to failure of treatment or death from any cause of IST versus URD BMT when used as initial therapy to treat SAA. The trial will also assess whether health-related quality of life and early markers of fertility differ between those randomized to URD BMT or IST, as well as assess the presence of marrow failure-related genes and presence of gene mutations associated with MDS or leukemia and the change in gene signatures after treatment in both study arms. This study treatment does not include any investigational drugs. The medicines and procedures in this study are standard for treatment of SAA.
Recruiting2 awards Phase 3

More about James Labelle

Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments James Labelle has experience with
  • Fludarabine
  • Alemtuzumab
  • Abatacept
  • Placebo
  • Cyclosporins
  • Mycophenolate Mofetil
Breakdown of trials James Labelle has run
Aplastic Anemia
Sickle Cell Disease
Acute Graft-versus-Host Disease
Graft-versus-Host Disease
Dyskeratosis Congenita

Other Doctors you might be interested in

Daniel Olson, MDUniversity of Chicago Comprehensive Cancer Center
Michael Thirman, MDUniversity of Chicago
Rita Nanda, MDUniversity of Chicago Comprehensive Cancer Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James Labelle specialize in?
James Labelle focuses on Aplastic Anemia and Sickle Cell Disease. In particular, much of their work with Aplastic Anemia has involved treating patients, or patients who are undergoing treatment.
Is James Labelle currently recruiting for clinical trials?
Yes, James Labelle is currently recruiting for 1 clinical trial in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that James Labelle has studied deeply?
Yes, James Labelle has studied treatments such as Fludarabine, Alemtuzumab, Abatacept.
What is the best way to schedule an appointment with James Labelle?
Apply for one of the trials that James Labelle is conducting.
What is the office address of James Labelle?
The office of James Labelle is located at: University of Chicago, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security